Because of its low invasiveness, low cost, and great conveniences, the development of blood biomarkers has been widely studied for stroke-onset prediction in recent years, and a series of biomarkers including alanine transaminase [13], phospholipase A2 [14], and neutrophil to lymphocyte ratio [15], etc. have been reported in succession. The gene discussed is GPT; the disease is stroke disorder.